Skip to content

RUDOPHAR

Active
Private limited companyfounded 1999active for 27 yearsTorhoutsestraat 19, 8020 Oostkamp, BelgiumKBO/BCE: BE 0466.316.513
Summary

RUDOPHAR has been active since 1999 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €425,968 and a net result of €74,117. Equity has been growing by about 7.9% per year since 2019. Its solvency ranks better than 90% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 18-06-1999 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 30-09-2025
Establishment unit
2.092.029.088 8020 Oostkamp, since 01-07-2002
Financial year end
30 September
Peppol
Reachable since 24-07-2025

Board and ownership

Board

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-09-2025
Gross margin
€161,702
▲ 31.3%
Turnover
≈ €750,000
estimated
Profit
€74,117
▲ 50.3%
Equity
€425,968
▲ 4.4%
Total assets
€526,499
▲ 5.9%
Employees on 30-09-2025
1
=
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 4.88, cash €186,553Equity €425,968 (80.9% of total assets)Founded in 1999Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 79% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 80.9% of total assets
Liquidity 89+5
short-term debt 18.4% · cash 35.4%
Profitability 86+5
return on assets 14.1%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: < 0.1% 01-2025: 0.1%▲ +0.1 percentage points vs 12-2024 02-2025: < 0.1%▼ -0.1 percentage points vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.1%▲ +0.1 percentage points vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026highest value 06-2026: < 0.1%▼ -0.1 percentage points vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €40,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.88 (5.08 in 2024), above the usual 1.5. Short-term debt is 18.4% and cash 35.4% of total assets. 19.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 91% on liquidity, 81% on profitability and 51% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 4.88, cash €186,553
NBB · annual accounts
lowers risk · Equity €425,968 (80.9% of total assets)
NBB · annual accounts
lowers risk · Founded in 1999
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 30-04-2026, 0 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
on the day
2024
36 days early
2023
33 days early
2022
31 days early
2021
46 days early
2020
24 days early
2019
16 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 27 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 29 March (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end03-11-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 89% of companies in retail tradesector median 36.6% · 12,775 companies 80.9% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €74,117 7 years View

Recent changes

  1. · Gazette deed Appointments: Verhelst Katia (statutair opvolgend bestuurder) and Vuylsteke Carl (statutory director)
  2. · Gazette deed Incorporation
All 13 events

Comparable companies

These companies have the same main activity as RUDOPHAR: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €485,000 and €636,000, founded between 1992 and 2006.

CompanyTotal assetsGross margin
RUDOPHAR Oostkamp€526,499€161,702
APOTHEEK PROXIPHAR Gent€508,811€172,164
APOTHEEK VANOVERSCHELDE Wingene€515,473€166,614
PHARMA STUBBE Ingelmunster€535,694€177,873
PHARMACIE JACQUES Courcelles€485,161€141,646
APOTHEEK MAST Merchtem€635,915€175,020
PHARMACIE DE LA REID Theux€563,954€143,500
Full comparison

Key facts about RUDOPHAR

What is the company number of RUDOPHAR?
The company number of RUDOPHAR is 0466.316.513. The VAT number is the same number with BE in front: BE 0466.316.513.
Where is RUDOPHAR based?
The registered office is at Torhoutsestraat 19, 8020 Oostkamp.Company details
What does RUDOPHAR do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of RUDOPHAR?
The legal form of RUDOPHAR is Private limited company (BV).
When was RUDOPHAR founded?
RUDOPHAR was founded on 18-06-1999.
Is RUDOPHAR still active?
Yes, RUDOPHAR is an active enterprise in the KBO register.
How many employees does RUDOPHAR have?
RUDOPHAR had an average of 0.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does RUDOPHAR fall under?
In its 30-09-2025 annual accounts, RUDOPHAR states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of RUDOPHAR?
The turnover in financial year 2025 is ≈ €750,000. This figure is estimated from the gross margin of €161,702 and 51 comparable companies (NACE 477). It probably lies between €510,000 and €1.5m.
Is RUDOPHAR profitable?
In financial year 2025, RUDOPHAR made a profit of €74,117.
Where can I find the annual accounts of RUDOPHAR?
RUDOPHAR filed 26 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of RUDOPHAR due?
RUDOPHAR must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.